323 (37.5%) of patients were prescribed a ULT and the recorded starting dose of allopurinol was 100mg daily for 73.8%. Titration of subsequent allopurinol doses was recorded in only 21% of patients.

Mumbai: Indoco Remedies Ltd. has announced the final approval of Allopurinol Tablets USP 200 mg through its Abbreviated New ...

Most stock of Adani Group companies advanced after Chairman Gautam Adani announce Rs 50,000 crore investment in Assam. Track ...

Indoco Remedies receives US FDA final approval to market allopurinol tablets USP 200 mg: Our Bureau, Mumbai Friday, May 23, 2025, 12:30 Hrs [IST] Indoco Remedies Ltd., a fully int ...

Indoco Remedies' share price rose after the company received final USFDA approval for its ANDA to market Allopurinol tablets ...

Indoco Remedies rose 1.28% to Rs 245.80 after the company announced that it has received final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug ...